Shared compound evidence record
Retatrutide (10mg)
Metabolic Research
Loading the shop...
In Stock
Retatrutide
30mg Lyophilised Powder
For laboratory research only.
Early Black Friday: 20% off. Automatically applied.
Quantity
1 vial
1
Buying more? Save up to 15%
Item total$153.59
Standard delivery$9.99
This selection, delivered$163.58AUD
Or choose express delivery for $15.99.
Estimate for these items only, before discount codes or payment fees. Final total in checkout.
No account needed · PayID / bank transfer
Analytical documentation
View published lab report99.676% purity reported
Catalogue-associated report; current inventory-lot match is not established. Confirm before relying on it.
Labelled quantity
30mg
Category
Metabolic Research
Next business day dispatch cutoff
Order within the current dispatch window
Melbourne cut-off time updates live every second.
Time Remaining
12:34:29
Dispatch follows payment confirmation. Delivery options and cutoff terms
Most Popular Peptides
Compare price, format and delivery
Check labelled amounts, delivery costs and what each format includes in the price guide.
Stable research navigation
Connected catalogue records
These links are based on catalogue family, evidence records, research topics and bundle composition. They do not imply therapeutic similarity.
Shared compound evidence record
Retatrutide (20mg)
Metabolic Research
Shared compound evidence record
Retatrutide Starter Bundle
Metabolic Research
Connected compound evidence
CJC-1295 (no DAC) (10mg)
GH-Signalling Research
Research library
Evidence and analytical context for this record
These resources separate compound identity, batch-quality questions and study evidence. A linked study does not establish that this catalogue material is equivalent to a medicine or investigational product.
Product Information
Retatrutide (30mg): laboratory research material
Retatrutide, also identified in the literature as LY3437943, is a synthetic peptide investigated at the GLP-1, GIP and glucagon receptors.
Presentation and analytical documentation
Supplied as a lyophilised powder. The product name states the nominal quantity for this catalogue format. Review the analytical-document status and the CoA library for available sample reports. Read the identifiers, methods and measured results in the actual report; do not assume that one record covers every vial or batch.
Research context
The listed formats differ in nominal vial mass. Compare the same compound and presentation, then review the analytical record for the relevant sample. A larger vial does not establish greater purity, receptor activity or experimental suitability. Consult the Retatrutide research guide for source context and evidence limits.
Laboratory preparation and storage
Use the material-specific documentation and a validated laboratory method to select solvent, concentration and storage conditions. Keep the sample identifier and preparation record with the experimental data. A labelled mass or purity result does not establish solution stability, sterility or suitability for a particular assay.
For laboratory research only. Not for human or veterinary use.
Frequently Asked Questions
What is Retatrutide?
Retatrutide, also identified in the literature as LY3437943, is a synthetic peptide investigated at the GLP-1, GIP and glucagon receptors.
